NRSN   $0.83  9.21% Market Closed After Close 0.83 0.0

NeuroSense Therapeutics Ltd.

EMA (20): 2026-02-18 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2026-02-18 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2026-01-14 the price crossed down the moving average line and demonstrates a downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

Trend Type turning down
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield 3.39%
EMA (20) date of signal Feb. 18, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield 3.39%
EMA (50) date of signal Feb. 18, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -17.57%
EMA (100) date of signal Jan. 14, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal March 4, 2026, 3 a.m.
MACD Signals bearish weakening
MACD Yield 0.0
MACD date of signal March 4, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 0.0
Stochastic date of signal March 4, 2026, 3 a.m.
Updated March 4, 2026, 8:43 p.m.